$3.49
+
$0.01 (0.29%)
End-of-day quote: 05/17/2024
NasdaqGM:CVAC
CureVac N.V. Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $595.30 | $591.94 | 0.00% | 1 | $227.24B |
| DHR | Danaher | NYSE | Outperform | $265.80 | $260.33 | 0.00% | 4 | $196.87B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| MRNA | Moderna | NasdaqGS | Outperform | $132.90 | $135.42 | 0.00% | 1 | $50.93B |
| BNTX | BioNTech | NasdaqGS | Outperform | $90.61 | $123.75 | 0.00% | 3 | $21.84B |
| 1548 | Genscript Biotech | SEHK | Buy | HK$12.38 | HK$3.96 | 0.00% | 0 | HK$26.30B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $47.01 | $34.00 | 0.00% | 2 | $2.40B |
